Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million

Reuters

03/12

Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million

Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL07922) on March 11, 2026, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2618973343"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618973343\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618973343?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 04:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618973343","market":"us","top_or_hot":-1,"title":"Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL07922) on March 11, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-12 04:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL07922) on March 11, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDLbPTyH7:1","article_id":"2618973343","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618973343","pubTimestamp":1773259369,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","KEQU":"基瓦尼科技"},"translate_title":"Kewaunee Scientific 2026财年第三季度税前收益增长26%至160万美元，国际销售额增长21%至1845万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KEQU":0.9},"content_text":"Kewaunee Scientific Q3 FY2026 pretax earnings rise 26% to 1.6 million while international sales jump 21% to 18.45 million\n    \n\n        Kewaunee Scientific reported fiscal Q3 sales of USD 69.4 million, up 3% year over year, and pretax earnings of USD 1.6 million, up 26%. Fiscal Q3 net earnings were USD 0.69 million, while diluted EPS was USD 0.23. International fiscal Q3 sales rose 21% to USD 18.45 million, with management citing higher billings principally in the Indian market. Domestic fiscal Q3 sales were USD 50.95 million, while management said profitability was impacted by lower manufacturing volumes across the laboratory construction portion of the business. Order backlog was USD 183.2 million as of Jan. 31, with cash on hand of USD 10.35 million.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL07922) on March 11, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}